Managing Combination Therapy in HR+, HER2-Negative Advanced Breast Cancer

Strategies to Improve Patient Care by Managing Combination Therapy in HR+, HER2-Negative Advanced Breast Cancer (T-AFB-1143645)

Marie Seitz, RN, MSN, NP
Nurse Educator
Quintiles, on behalf of Novartis Pharmaceuticals Corporation

Tuesday, December 6, 2016
6:30 PM

Program Location:
Left Bank
377 Santana Row, Suite 1100
San Jose, CA 95128
(408) 984-4229

On behalf of Novartis Pharmaceuticals Corporation
RSVP by 12/01/2016
George Romanowsky
Novartis Representative
Program Host
(408) 726-4116 (Mobile)
george.romanowsky@novartis.com

Download the event flier here

The information you submit will be used by Novartis and business partner, AHM, to register and
communicate regarding this event

Novartis acts in accordance with the PhRMA Code on Interactions with Healthcare Professionals. The PhRMA Code states that inclusion of a Healthcare Professional’s spouse or guest at an educational program is not appropriate. Your support of these ethical guidelines will help to ensure a high quality learning environment for all participating Healthcare Professionals. Thank you.
Program Code: 16‐QTWBHC‐9 (16103070)